Full range of solutions
Pharmaprocess forum offered you a full range of learning opportunities to help you to enhace your business.In-depth sessions and specialist topics with the main experts of the pharmaceutical industry.
Check out the programme
27 OCTOBER | |||||
REGULATORY & DEVELOPMENT Management strategy to reduce time to market | OPERATIONS Factories for the future | GOOD DISTRIBUTION PRACTICES Regulatory impact from procurement to the client | BUSINESS DEVELOPEMENT Future and current business | ||
09:30-10:00 | RECEPTION | ||||
10:00 - 10:30 | Introduction: Mr. Ton Capella - PHARMAprocess President | ||||
10:30-11:30 | PLENARY: THE FIGHTING IN SPAIN AGAINST COUNTERFEITING: THE DIRECTIVE AND THE DELEGATE ACT | ||||
11:30-12:00 | COFEE BREAK AND VISIT THE EXHIBITION AREA - LEVEL 0 | ||||
12:00-13:00 | DATA INTEGRITY, A NOVARTIS APPROACH | BARRIER TECHNOLOGY (ISOLATOR AND RABS) TRENDS AND ITS MANAGEMENT | INDUSTRY SESSION | NUTRACEUTICALS ARE PART OF THE FUTURE?. NYADITUM RESAE® A SUCCESFUL CASE | |
13:00-14:00 | ANEX 15 AND NEW FDA/EMA VALIDATION GUIDE | GROUNDBREAKING PCMM CONCEPT | GDP. WHAT IS THE IMPACT TO THE API MANUFACTURERS? | INDUSTRY SESSION | |
14:00-15:30 | NETWORKING LUNCH - LEVEL 0 (Only for delegates) | ||||
15:30-16:30 | INDUSTRY SESSION | THE CHEMICAL AND PHARMACEUTICAL PROCESSES FROM THE BIG DATA POINT OF VIEW: A TRULY INNOVATION | GDP. WHAT IS THE IMPACT TO THE DISTRIBUTORS? | DEAL TRENDS: BD AND PRODUCTION IMPACTS | |
16:30-17:30 | MEDICAL DEVICE INNOVATION | INDUSTRY SESSION | GDP. WHAT IS THE IMPACT TO THE FDF MANUFACTURERS? | CHANNELING NICHE PHARMA PRODUCTS TO EUROPEAN MARKET | |
17:45 | PHARMA Experience – TECHNICAL GUIDED VISIT AT ALMIRALL PHARMA PLANT | ||||
18:00 | PHARMA Experience – TECHNICAL VISIT AT BARCELONA BIOMEDICAL RESEARCH PARK (PRBB) |
28 OCTOBER | ||||
REGULATORY & DEVELOPMENT Management strategy to reduce time to market | OPERATIONS Factories for the future | GOOD DISTRIBUTION PRACTICES Regulatory impact from procurement to the client | BUSINESS DEVELOPEMENT Future and current business | |
9:30-10:30 | PLENARY: ADVANCED METHODS FOR OPERATIONAL EXCELLENCE Dr. Hirozuki Sugiyama, Associate Professor - The University of Tokyo - Board Member of ISPE Japan / Mr. Ángel Albizu Mardones, Senior Leader Consultant - ASENTA Management Consultants Moderator: Mr. Xavier Farrés Torrecabota, Operations Director - Uriach | |||
10:45-11:45 | MARKET ACCES INTEGRATION IN QBD STRATEGY Ms. Mercedes Prior, Head of Global Market Access - Global Medical Affairs & Market Access - Almirall / Moderator: Mr. Carlos Maestro, Board of Director Member - ISPE Spain Affiliate | COST COMPARISON BETWEEN EU/USA AND EMERGING PLANTS. OPEX BENCHMARKING Mr. Nicolás Ponce, Research Associate Institute of Technology Management, University of St. Gallen / Moderator: Dr. Carles Cirera, Vice Chair - ISPE | CEIV PHARMA PROJECT Mr. Francisco Rizzuto, Cargo Manager for Western Europe - IATA - International Air Transport Association / Mr. Jaume Adrover Rigo, General Director - Gestió i Promoció Aeroportuària (GPA) / Moderator: Dr. Carmen Martínez, Senior Advisor - GRF & Partners | INDUSTRY SESSION HIGH SOPHISTICATED TECHNOLOGIES FOR OSD: HOTMELT GRANULATION AND COATING Mr. Thomas B. Kordik, Area Sales Manager - Romaco Innojet GmbH / Dr. Detlev Haak, Director R&D - Hermes Arzneimittel GmbH, Division HERMES Pharma / Moderator: Mr. Santiago Alsina, Scientific Coordinator - PHARMAprocess |
11:45-12:15 | COFFEE BREAK AND VISIT EXHIBITION AREA - LEVEL 0 | |||
12:30-13:30 | QbD AT MINIMUM OR "FULL APPLICATION" | INDUSTRY SESSION SAVE COST WITH PROPORTIONAL VALVE TECHNOLOGY FOR INERT GASES Mr. Thomas Schulz, Head of Industry segment & Key Account management Biotech/Pharma/Cosmetics - Festo AG & Co. KG / Moderator: Mr. Juan Núñez García, Operationa Excellence Responsible - Almirall | CIRCULAR ECONOMY AND ECOLOGICAL INTELLIGENCE: LIFE CYCLE AND CARBON FOOTPRINT WITHIN THE PHARMA SECTOR Dr. Pere Fullana i Palmer, UNESCO Chair in Life Cycle and Climate Change - ESCI-UPF / Moderator: Ms. Elvira Carles, Directora - Fundació Empresa i Clima | HOW TO BE AN EFFICIENT DIGITAL PLANT Mr. Rocco Lisi - Accenture / Moderator: Mr. Carlos Maestro, Board of Director Member - ISPE Spain Affiliate |
13:30-15:00 | NETWORKING LUNCH - LEVEL 0 (Only for delegates) | |||
15:00-16:00 | NANO-DRUG DELIVERY Ms. Mª José Alonso, Professor - University of Santiago de Compostela / Prof. Dr. Víctor F. Puntes, Professor VHIR / Moderator: Ms. Beatriz Artalejo, President - AEFI | INDUSTRY SESSION CONTINOUS LYOPHILLIZATION Mr. Robert Bullich, Process Laboratory Manager - Azbil Tesltar Technologies / Moderator: Dr. Enric Jo, Site Director - Reig Jofre Group | SUPPLY SHORTAGE IN A GLOBAL CONTEXT Ms. Alison Dawson, QA Leader - EU Ext. Advocacy & Collabns - Lilly / Moderator: Mr. Salvador Cassany, Head of Pharmaceutical and Medical Devides Control Unit - Ministry of Health - Generalitat de Catalunya | MARKET ACCESS CONSIDERATIONS IN ASSET VALUATION Ms. Monique Martin, Vice President and General Manager - Mapi / Moderator: Ms. Rosa-Marta Domènech Montagut,Commercial Excellence Head- Novartis Farmacéutica, S.A. |
16:15-17:15 | PLENARY: DIGITAL MANUFACTAURING IN PHARMA INDUSTRY Mr. Ben Salama, Managing Director - Accenture / Mr. Jordi Ibañez, Managing Director lead for Life Sciences - Accenture / Moderator: Mr. Joan Navales, Operations Director - Laboratorios Dr. Esteve | |||
17:25-19:00 | |